Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Residential Lead Interventions’ Effect on Children

JAMA Pediatrics; ePub 2018 Aug 27; Braun, et al

Residential lead exposures, as well as blood lead concentrations in non-Hispanic black children, were reduced through a comprehensive lead-hazard intervention without elevating the lead body burden, according to a recent, randomized clinical trial of pregnant women and their children. This decrease, however, did not result in substantive neurobehavioral improvements in children. Pregnant women attending 1 of 9 prenatal care clinics were recruited. Of 1,263 eligible women, 468 (37.0%) agreed to participate and 355 women (75.8%) were randomized in this intention-to-treat analysis. Participants were randomly assigned to receive 1 of 2 interventions designed to reduce residential lead or injury hazards. Follow-up on children took place at 1, 2, 3, 4, 5, and 8 years of age. Researchers found:

  • The intervention did not statistically significantly reduce childhood blood lead concentrations.
  • Neurobehavioral test scores were not statistically different between children in the intervention group than those in the control group except for a reduction in anxiety scores in the intervention group.
Citation:

Braun JM, Hornung R, Chen A, et al. Effect of residential lead-hazard interventions on childhood blood lead concentrations and neurobehavioral outcomes. A randomized clinical trial. [Published online ahead of print August 27, 2018]. JAMA Pediatrics. doi:10.1001/jamapediatrics.2018.2382.

This Week's Must Reads

Outpatient Utilization Patterns for AD in the US, J Am Acad Dermatol; ePub 2019 Mar 15; Singh, et al

Racial Disparities in Healthcare Utilization for AD, J Invest Dermatol; ePub 2019 Mar 13; Wan, et al

Sleep Disturbances in Mothers of Children with AD, JAMA Dermatol; ePub 2019 Mar 20; Ramirez, et al

Childhood AD in the Primary Care Setting, J Am Board Fam Med; 2019 Mar-Apr; Al-Naqeeb, et al

Must Reads in Mental Health

FDA Approves Adhansia XR for ADHD, Adlon Therapeutics news release; 2019 Mar 1

Predictors of Victimization of Overweight Youth, Pediatr Obes; ePub 2019 Feb 14; Nabors, et al

Report Card Release, Link to Child Abuse Examined, JAMA Pediatrics; ePub 2018 Dec 17; Bright, et al

Antipsychotic Treatment Risk in Children and Youths , JAMA Psychiatry; ePub 2018 Dec 12; Ray, Stein, et al